Discovery of a novel natural compound, vitekwangin B, with ANO1 protein reduction properties and anticancer potential

Conclusion: Vitekwangin B may offer a new direction for cancer therapy by targeting ANO1 protein, potentially improving treatment outcomes in patients with prostate cancer and NSCLC. Further research is needed to explore its full potential and overcome existing drug resistance challenges.
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research